In conclusion, Raman spectroscopy holds significant promise as an intraoperative tool to address key challenges in glioma surgery, including tumor delineation, glioma grading, glioma subtyping, IDH status determination and differentiation from other CNS lesions. This evidence concerns the gene IDH1 and glioma.